Melissa Faris

Melissa Faris currently serves as Chief Business Officer at OMass Therapeutics since November 2023. Previously, extensive experience at GSK spanned over two decades, with roles including VP and Head of Immunology Business Development and several leadership positions in Business Development. Additional experience includes serving as a Board Member at Sitryx and a Personal Sabbatical at GLAXOSMITHKLINE PLC. Earlier career roles involved clinical research and development positions at Glaxo Wellcome and the University of North Carolina at Chapel Hill. Melissa Faris holds a PharmD from The Ohio State University and a BS in Pharmacy from West Virginia University.